Epic Medical Research

Epic Medical Research

Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Funding information not available

Overview

Epic Medical Research is a private clinical research services company that has been operating since 2015. It functions as a site management organization (SMO) or niche CRO, conducting clinical trials for sponsors, with a stated focus on digital health and a patient-centered approach across five southern US states. The company appears to be in a revenue-generating phase, providing trial execution services rather than developing its own therapeutic assets. Its model leverages a decentralized or multi-site network to recruit and manage patients for clinical studies.

Digital Health

Technology Platform

Operational infrastructure for decentralized/hybrid clinical trials, including patient recruitment tools, EDC systems, telehealth capabilities, and data management protocols for digital health interventions.

Opportunities

The company is positioned to capitalize on the rapid growth of decentralized clinical trials and the digital therapeutics market.
Its regional network in the southern US provides access to a large and diverse patient population, a key advantage for sponsor recruitment goals.
Increasing regulatory acceptance of digital endpoints creates sustained demand for specialized CRO expertise.

Risk Factors

Key risks include operational execution risk in complex trials, client concentration risk, and intense competition from both large global CROs and other niche players.
The company's fortunes are also tied to the investment and regulatory cycles specific to the digital health sector, which could be volatile.

Competitive Landscape

Epic competes in the fragmented Clinical Research Organization (CRO) market. It faces competition from giant global CROs (e.g., IQVIA, LabCorp, PPD) and larger mid-sized players, as well as other niche, regional site networks and digital health-specialized CROs. Its differentiation lies in its focused geographic footprint and stated specialization in patient-centered, digital health trials.